MayaEGuglinMD

Cardiology • Indianapolis, IN

Adult Congenital Heart Disease, Heart Failure & Transplantation, Interventional Cardiology

Director, Heart Failure and Transplant/Assist Devices, University of South Florida

Join to view full profile

Dr. Guglin is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Guglin's full profile

Already have an account?

Office
1801 Senate Blvd
Indianapolis, IN 46202
Phone+1 317-962-9700

Fax+1 317-962-9704

Education & Training

Cooper Medical School of Rowan University/Cooper University HospitalFellowship, Cardiovascular Disease, 2000 - 2003
Columbia Saint Luke's Medical CenterResidency, Internal Medicine, 1997 - 2000
The Volgograd State Medical UniversityClass of 1984

Certifications & Licensure

IN State Medical License 2019 - 2025
NJ State Medical License 2000 - 2025
KY State Medical License 2014 - 2020
FL State Medical License 2006 - 2015
MI State Medical License 2003 - 2007
OH State Medical License 1999 - 2005
American Board of Internal Medicine Advanced Heart Failure and Transplant Cardiology
American Board of Internal Medicine Cardiovascular Disease

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2012-2013
Fellow (FACC) American College of Cardiology

Clinical Trials

Lisinopril or Coreg CR® in Reducing Side Effects in Women With Breast Cancer Receiving Trastuzumab Start of enrollment: 2010 Mar 01
Completed
Phase 2
Low Sodium vs. Regular Diet in Patients Admitted for Heart Failure Start of enrollment: 2016 Nov 01
Terminated
Not Applicable
Effects of Metformin in Heart Failure Patients Start of enrollment: 2016 Nov 01
Withdrawn
Not Applicable

Publications & Presentations

PubMed

5 citations
Fulminant Myocarditis and Cardiogenic Shock Following COVID-19 Infection Versus COVID-19 Vaccination: A Systematic Literature Review.
Maya E Guglin, Aniekeme Etuk, Chirag Shah, Onyedika J Ilonze
Journal of Clinical Medicine. 2023-02-25
672 citations
Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure.
Maria Rosa Costanzo, Maya Guglin, Mitchell T. Saltzberg, Mariell Jessup, Bradley A. Bart
Journal of the American College of Cardiology. 2007-02-13
53 citations
Drug-Induced Takotsubo Cardiomyopathy.
Kazuhiko Kido, Maya Guglin
Journal of Cardiovascular Pharmacology and Therapeutics. 2017-05-11

Abstracts/Posters

[Board 509] Chemotherapy-Induced Cardiomyopathy: Anthracyclines and Trastuzumab Require Different Approach to Monitoring and Prevention
Maya Guglin, 2019 ACC Scientific Session & Expo, New Orleans, New Orleans, 3/17/2019

Lectures

Noncompaction Cardiomyopathy: More than Just Trabeculations
2019 ACC Scientific Session & Expo, New Orleans - 3/17/2019

Press Mentions

Study Calls for Targeted Strategies for Managing Diabetic Cardiomyopathy Across Racial, Ethnic GroupsJuly 8th, 2024
Dobutamine Shortage: ACC Experts Offer Tips, AlternativesAugust 11th, 2022
Feature | What You Need to Know: Guidance for Clinicians on Dobutamine ShortageAugust 2nd, 2022
Join now to see all

Professional Memberships

American College of Cardiology - ACC
Member